Sign in Request access
Sign inRequest access
OpenTender 31 Dec 2028, 23:58 (UTC+01:00)

Open House Biologika Rabattverträge 2026 - 30 Dornase alfa

At a glance

Techniker Krankenkasse is procuring Pharmaceutical products (CPV 33600000) in Hamburg (DE600). The notice gives 31 December 2028, 23:58 (UTC+01:00) as the deadline. Procedure type: Open.

From the notice

Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Dornase alfa zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Verfahrens der TK: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die TK sichert einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 24 Monate beginnend mit dem 01.01.2027. Der Vertrag endet spätestens am 31.12.2028, unabhängig vom Datum des Vertragsschlusses. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen.

Key facts

Each fact is from the official notice, last checked 27 October 2026, 00:30 (UTC+01:00).

Status
OpenOfficial notice · checked 27 Oct 2026, 00:30 (UTC+01:00)
Deadline
(in 785 days)Official notice · checked 27 Oct 2026, 00:30 (UTC+01:00)
Buyer
Techniker Krankenkasse, Hamburg, DEOfficial notice · checked 27 Oct 2026, 00:30 (UTC+01:00)
Place of performance
Hamburg (DE600)Official notice · checked 27 Oct 2026, 00:30 (UTC+01:00)
Main CPV
Pharmaceutical products (CPV 33600000)Official notice · checked 27 Oct 2026, 00:30 (UTC+01:00)
Procedure
OpenOfficial notice · checked 27 Oct 2026, 00:30 (UTC+01:00)
Lots
1Official notice · checked 27 Oct 2026, 00:30 (UTC+01:00)
First published
16 October 2026, 08:19 (UTC+02:00)Official notice · checked 27 Oct 2026, 00:30 (UTC+01:00)

Fact sheet

Inteliwert fact sheet: Open House Biologika Rabattverträge 2026 - 30 Dornase alfa — Techniker Krankenkasse, deadline 31 December 2028, 23:58 (UTC+01:00). A product of Bandpey GmbH.
The key facts of this page as an image (PNG, 1600 × 900), made from the official notice. © Bandpey GmbH; terms of use. Download the fact sheet

Lots (1)

  1. Lot LOT-0001: Open House Biologika Rabattverträge 2026 - 30 Dornase alfa

    Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Dornase alfa zu schließen.

    CPV
    Pharmaceutical products (CPV 33600000)
    Place
    Hamburg (DE600)
    Deadline

Timeline

  1. 16 October 2026, 08:19 (UTC+02:00): Original notice Notice, version 01 (Contract or concession notice – standard regime). Official notice

Buyer and place

Buyer

Techniker Krankenkasse
Hamburg, DE

Place of performance

  • Hamburg (DE600)

Classification

CPV codes

  • 33600000: Pharmaceutical products

NUTS regions

  • DE600: Hamburg

Official documents

Links go to the publisher. Inteliwert does not copy the documents.

Questions and answers

When is the deadline?

The official notice gives 31 December 2028, 23:58 (UTC+01:00) as the deadline.

Who is the buyer?

Techniker Krankenkasse, Hamburg, DE.

What is being procured (CPV)?

Pharmaceutical products (CPV 33600000).

Where is the work performed (NUTS)?

Hamburg (DE600).

Is it divided into lots?

No, the notice names a single lot.

Which procedure is used?

Open.

How do I submit a bid?

On the official notice or the portal it names. Inteliwert does not submit bids. Official notice

Am I eligible?

Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice

Companies that might fit

Possible match based on public information

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

  • Bluefish Pharma GmbH

    Griesheim
    SME (from the award notice)
    • Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
    • Seat in the same country as the place of performance Evidence · checked 4 Nov 2026

  • Gedeon Richter GmbH

    Eschborn
    SME (from the award notice)
    • Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
    • Seat in the same country as the place of performance Evidence · checked 4 Nov 2026

  • Amarox Pharma GmbH

    Haar
    SME (from the award notice)
    • Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
    • Seat in the same country as the place of performance Evidence · checked 4 Nov 2026

  • HEC Pharm GmbH

    Berlin
    SME (from the award notice)
    • Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
    • Seat in the same country as the place of performance Evidence · checked 4 Nov 2026

  • Holsten Pharma GmbH

    Frankfurt am Main
    SME (from the award notice)New to public tenders
    • Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
    • Seat in the same country as the place of performance Evidence · checked 4 Nov 2026

More from this buyer

Other published opportunities of this buyer in the indexed notices, open ones first.

Source

Publisher
Bekanntmachungsservice
Licence
CC0 1.0
Last checked
27 October 2026, 00:30 (UTC+01:00)

The official notice is authoritative. Inteliwert shows what the notice states and links to it.

Markdown version